Bottom line
JDOC vs JEHSX: the short answer
JDOC (JPMorgan Healthcare Leaders ETF) and JEHSX (Health Sciences Trust) share a meaningful slice of their top holdings — about 58% by weight.
But JEHSX is far broader, holding 173 positions to 61 for JDOC, so beyond the top names it adds exposure JDOC doesn't have.
JDOC is cheaper at 0.65% vs 1.04% — a difference of $39 a year per $10,000 invested.
Over one year, JEHSX returned +19.5% vs +14.9% for JDOC.
Updated Nov 19, 2026
JDOC vs JEHSX side by side
| JDOC | JEHSX | |
|---|---|---|
| Type | ETF | Mutual fund |
| Fund family | J.P. Morgan | John Hancock |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 0.65% | 1.04% |
| Annual cost per $10k | $65 | $104 |
| 10-yr cost on $10k (prospectus) | $810 | $1,282 |
| Max front load | None | — |
| 12b-1 fee | — | 0.05% |
| 1-yr return | +14.9% | +19.5% |
| 5-yr return (annualized) | — | +4.2% |
| 10-yr return (annualized) | — | +8.7% |
| Best quarter | +11.3% | +23.6% |
| Worst quarter | −11.9% | −16.1% |
| Net assets (fund) | $9.1M | $251.3M |
| Number of holdings | 61 | 173 |
| Portfolio turnover | 92% | 68% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | JDOC | JEHSX | Difference |
|---|---|---|---|
| 2025 | +14.9% | +19.5% | −4.5% |
| 2024 | −0.6% | +1.8% | −2.4% |
Source: Fund prospectus bar charts
Holdings overlap
13 of JDOC's top 25 holdings also appear in JEHSX's top 25.
| Holding | JDOC | JEHSX |
|---|---|---|
| AbbVie, Inc. | 7.85% | 5.28% |
| Eli Lilly & Co. | 7.76% | 14.30% |
| UnitedHealth Group, Inc. | 5.85% | 5.95% |
| Merck & Co., Inc. | 4.82% | 4.21% |
| Johnson & Johnson | 4.82% | 6.33% |
| Thermo Fisher Scientific, Inc. | 3.73% | 2.67% |
| Bristol-Myers Squibb Co. | 3.57% | 2.22% |
| Abbott Laboratories | 3.11% | 2.00% |
| CVS Health Corp. | 2.83% | 0.98% |
| Stryker Corp. | 2.23% | 1.87% |
| Danaher Corp. | 2.16% | 1.51% |
| Intuitive Surgical, Inc. | 1.93% | 1.98% |
| Cardinal Health, Inc. | 1.51% | 1.09% |
Source: SEC Form N-PORT
JDOC top 10
- AbbVie, Inc. — 7.85%
- Eli Lilly & Co. — 7.76%
- UnitedHealth Group, Inc. — 5.85%
- Merck & Co., Inc. — 4.82%
- Johnson & Johnson — 4.82%
- AstraZeneca plc — 3.76%
- Thermo Fisher Scientific, Inc. — 3.73%
- Bristol-Myers Squibb Co. — 3.57%
- Abbott Laboratories — 3.11%
- CVS Health Corp. — 2.83%
JEHSX top 10
- Eli Lilly and Company — 14.30%
- Johnson and Johnson — 6.33%
- UnitedHealth Group Incorporated — 5.95%
- AbbVie Inc. — 5.28%
- Merck and Co. Inc. — 4.21%
- Gilead Sciences Inc. — 2.95%
- Thermo Fisher Scientific Inc. — 2.67%
- Vertex Pharmaceuticals Incorporated — 2.38%
- Bristol-Myers Squibb Company — 2.22%
- Abbott Laboratories — 2.00%
FAQ
What is the difference between JDOC and JEHSX?
Which is cheaper, JDOC or JEHSX?
Should I own both JDOC and JEHSX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.